Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 25 Sep 20 424B4 Prospectus supplement with pricing info
- 25 Sep 20 EFFECT Notice of effectiveness
-
21 Sep 20 S-1/A IPO registration (amended)
- 16 Sep 20 S-1/A IPO registration (amended)
- 4 Sep 20 S-1 IPO registration
PRLD similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 23, 2020 (except for the reverse stock split described in Note 11, as to which the date is September 21, 2020), in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-248628) and related Prospectus of Prelude Therapeutics Incorporated dated September 21, 2020.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
September 21, 2020